In focus
Latest feed
A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus
A Glimmer of Hope: New Alzheimer's Drug Shows Remarkable Safety in Early Trial
The No Surprises Act's Unintended Consequence: A Multi-Billion Dollar Headache for Healthcare
When Artificial Intelligence Meets Hospital Leadership: Why CEOs Must Own the Accountability Conversation
